BACKGROUND/OBJECTIVES: Mild to moderate vitamin D insufficiency has been proposed as a risk factor for several common chronic diseases including type 2 diabetes. This study aimed to examine the association between serum 25-hydroxy vitamin D (25(OH)D) and incident diabetes. SUBJECTS/METHODS: The MONICA10 cohort consists of 2656 participants (men and women aged 41-71 years) who participated in a 10-year follow-up examination during 1993-1994 as part of the MONICA 1 population survey. A total of 2571 participants free of diabetes at baseline and with successful measurement of serum 25(OH)D were included in the current study. The Danish National Diabetes register enabled identification of 288 cases of incident diabetes during follow-up (median: 16.4 years). Data were analysed by Cox proportional hazard models and associations were expressed as hazard ratios (HRs) with 95% confidence intervals (CIs). 
INTRODUCTION
For most people the main source of vitamin D is synthesis in the skin following exposure to sunlight. 1, 2 Inhabitants of countries at latitudes above 401N, e.g., Denmark (561N), cannot produce sufficient amounts of vitamin D during the winter, and the main source of vitamin D during the winter months is from the diet. 2, 3 Only a few foods such as oily fish and egg yolk naturally contain vitamin D in nutritionally relevant quantities, and Denmark has been restrictive with regards food fortification, resulting in very few vitamin-D-fortified food items on the Danish market. Thus, low vitamin D status is likely to be prevalent in Denmark, and indeed has been shown in the general population. 4 It is well known that severe vitamin D deficiency may lead to bone-deforming rickets disease in children and the development of osteoporosis and osteomalacia in adults. Moreover, mild to moderate vitamin D insufficiency has been linked to several common chronic diseases including diabetes. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] The potential role of vitamin D in diabetes is supported by the expression of the vitamin D receptor in pancreatic beta-cells, skeletal muscle and adipose tissue. 15 Inverse associations between serum 25(OH)D and type 2 diabetes have been reported in many cross-sectional studies. 3, 4 However, the major drawback of these studies is the potential for reverse causation i.e., diabetes causing low vitamin D status rather than vice versa. Inverse associations have also been reported in prospective studies, but the data are inconsistent. [16] [17] [18] [19] [20] [21] [22] Some prospective studies measured the dietary intake of vitamin D, [23] [24] [25] which does not account for the large proportion of vitamin D produced in the skin. Other prospective studies used blood 25(OH)D as a biomarker but ascertained diabetes by selfreport 17, 18 or by medication registry data, 16, 19 which do not take into consideration undiagnosed individuals or those who treat their disease by dietary changes only.
The aim of this study was to examine the association between serum 25(OH)D status and the risk of incident registry-based type 2 diabetes in a cohort recruited from the Danish general population.
SUBJECTS AND METHODS

Study population
The Danish Monitoring Trends and Determinants of Cardiovascular Disease (MONICA) 1 population survey took place from 1982 to 1984, and included 4807 men and women born in 1922, 1932, 1942 or 1952 who were randomly selected from 11 municipalities in the former Copenhagen County. The participation rate was 78.7% (n ¼ 3785). The MONICA 10 population consists of 2656 individuals who agreed to participate in a follow-up examination during 1993-1994. At the time of the MONICA 10 examination, the participants were 41, 51, 61 or 71 years old. The health examination included self-administered questionnaires, a physical examination and various blood tests. The study was approved by the Ethical Committee of Copenhagen and was in accordance with the principles of the Helsinki Declaration II.
Definition of registry-based incident diabetes
Registry-based incident diabetes was defined as new cases of diabetes during follow-up among those without diabetes at baseline based on information from the Danish National Diabetes Register. This registry uses five diagnostic criteria: hospitalization with a diagnosis of diabetes (International Classification of Disease (ICD)-8: 249 or 250, ICD-10: DE10-14, DH 36.0 or DO24 (excluding D ¼ 24.4)); registration of chiropody (coded for diabetes) in the National Health Insurance Service Registry; frequent measurements of blood glucose either at least five times within 365 days (1 year), or at least two annual measurements of glucose during a 5-year period (registered in the National Health Insurance Service Registry); and prescription of insulin or oral anti-diabetic medication at least twice (registered in the Register of Medicinal Product Statistics). 26 If one of these criteria is met the subject is classified as having diabetes. Participants classified as having diabetes prior to the date of examination in the MONICA10 study (1993) (1994) were excluded from the study (n ¼ 62). Participants who were not included in the diabetes register, but selfreported diabetes at baseline, were also excluded (n ¼ 17). Participants without diabetes (n ¼ 2577) were followed from the date of examination (between 14 June 1993 and 2 December 1994) to 31 December 2010, or to the date at which the individual emigrated (n ¼ 16), died (n ¼ 474) or developed diabetes (n ¼ 290), whichever date came first. Information on emigrations and deaths was obtained from the Danish Civil Registration System. In Supplementary analyses participants developing diabetes within the first year of follow-up were excluded (n ¼ 22).
Measurement of serum 25(OH)D
Vitamin D status was measured as serum 25(OH)D using the IDS ISYS immunoassay system based on chemiluminescence technology (IDS Nordic A/S, Copenhagen, Denmark). 27 Fasting blood was collected in 1993-1994, and serum samples stored at À 20 1C until analysis in 2011. Serum 25(OH)D was measured successfully in 2571 (288 new cases, 2283 controls) out of the 2577 participants without diabetes at baseline, who were thus included in the study.
Self-administered questionnaire
The self-administered questionnaire included information on lifestyle habits, medical history, sociodemographic variables and other potential confounders. Family history of diabetes was defined as having a firstdegree relative with diabetes. Educational level was categorized in four groups (none, low, medium, high) ranging from no vocational qualifications to 44 years of theoretical education. The average weekly alcohol intake was categorized in five groups as 0, 1-7, 47-14, 414-21 or 421 standard (approx. 1.5 cl or 12 g ethanol) drinks per week.
Physical activity during leisure time was reported as sedentary, light, moderate or vigorous. Smoking status was never; ex-smoker; or current smoker at o15, X15-25, or X25 grams of tobacco/day. Dietary intake of fish was categorized as once a month or less, 2-3 times a month, once a week or more than once a week. A predefined healthy food index was also calculated by giving one point for each of the following four self-reported characteristics of the diet: (1) not consuming butter, lard or margarine daily, (2) consuming either raw or boiled vegetables at least once daily, (3) consuming either coarse white or coarse rye bread at least once daily, and (4) consuming fruit at least once daily. 28 Use of dietary supplements was also recorded. Finally, a self-reported history of cardiovascular diseases (CVD) was defined as a confirmatory answer to the question: has a doctor ever told you that you have had a heart attack or a stroke? Participants reporting a history of CVD were excluded from Supplementary analyses.
Anthropometrics
Waist circumference (WC) was measured without clothes midway between the lower rib margin and iliac crest, and categorized as normal (women: p80 cm; men: p94 cm), overweight (women: 480-88 cm; men: 494-102 cm), or obese (women: 488 cm; men: 4102 cm). Height and weight were measured when wearing light clothes and no shoes. Body mass index (BMI) was calculated as weight divided by height squared, and categorized as underweight (o18.5 kg/m 2 ), normal (X18.5-25 kg/m 2 ), overweight (X25-30 kg/m 2 ), or obese (X30 kg/m 2 ). The categories 'underweight' and 'normal' were combined due to the low number of participants (n ¼ 25) in these categories and lack of cases of diabetes during follow-up in the underweight category. Electrical impedance was measured using a BIA-103 body-composition analyser (RJL Systems, Detroit), and percentage body fat was calculated as described previously. 29 
Statistical analyses
Statistical analyses were performed using SAS, version 9.3 (SAS Institute Inc, Cary, NC, USA). All reported P values are two-tailed and statistical significance was defined as Po0.05.
Multivariate Cox regression analyses were used to determine the association of baseline serum 25(OH)D and the incidence of diabetes. Individuals with diabetes at baseline were excluded. Estimates are presented as hazard ratios (HR) with 95% confidence intervals (95% CI). We used delayed entry and age as the underlying time axis. The few participants lost to follow-up (i.e. those who emigrated or died) contributed to the risk time until the date of their last registered activity. Models were adjusted for sex, season of blood collection, WC, history of CVD, family history of diabetes, physical activity during leisure time, healthy food index, fish intake, supplement use, smoking status, alcohol intake and educational level. In Supplementary analyses WC was substituted with BMI and percentage body fat. Continuous variables (25(OH)D, alcohol consumption, WC, BMI, and percentage body fat) were tested for linear associations by including the squared term of the variable in the model. Alcohol consumption, WC and BMI were categorized as described above due to significant non-linear associations. Linear trends across ordered groups were calculated by scoring the groups and including this variable as a continuous variable in the model. Statistical interaction effects were evaluated by including a product term between 25(OH)D and the relevant covariates. The proportional hazards assumption was verified by testing for an interaction between log(time) and e.g. 25(OH)D.
RESULTS
The study included 1276 (49.6%) men and 1295 (50.4%) women without known diabetes at baseline. The mean age at baseline was 55 years (range: 41-72 years). Median serum 25(OH)D was 61.2 nmol/l (5th-95th percentiles: 27.5-115.6 nmol/l). Other baseline characteristics as well as the crude associations of these potential confounders with serum 25(OH)D and incident diabetes are shown in Table 1 . Lower 25(OH)D concentrations were associated with higher age, blood collection during winter months, obesity, a family history of diabetes, low educational level, smoking, low fish intake, a less healthy food index score and no use of supplements. A higher incidence of diabetes was significantly associated with male gender, higher age, higher WC, higher BMI, higher percentage body fat, family history of diabetes, non-drinking, high alcohol intake and a less healthy food index score.
A total of 288 participants developed diabetes during a median follow-up of 16.4 years (range: 0.07, 17.5). Serum 25(OH)D was inversely associated with incident diabetes adjusted for age, sex, season of blood collection, waist circumference, family history of diabetes, history of CVD, physical activity during leisure time, healthy food index, fish intake, supplement use, smoking status, alcohol intake and educational level (HR (95%CI) per 25 nmol/l higher 25(OH)D ¼ 0.83 (0.72-0.95); P ¼ 0.009) ( Table 2 ). In stepwise analyses adjustment for WC produced the greatest change in the risk estimate (Supplementary Information Table 1 Table 3 ). Thus, the association between 25(OH)D and diabetes was only observed in individuals with a high WC or BMI, and not in normal weight individuals. No statistically significant interaction effect was observed with fat mass measured as percentage of body fat, although a similar tendency was observed ( Table 3 ). The intercorrelations between WC, BMI and percentage body fat were 0.82 (WC and BMI), 0.35 (WC and body fat) and 0.69 (BMI and body fat), respectively (all P values o0.001).
DISCUSSION
We found that low serum 25(OH)D was significantly associated with incident diabetes. The association appeared to be independent of several potential confounders. The association was only The major strengths of this study include its prospective study design and the long follow-up period, which allowed for the assessment of temporal relationships. In addition, we used data from the Danish National Diabetes Register, which ensured almost complete follow-up and an objective standardized definition of diabetes. Unfortunately, this register does not distinguish between different types of diabetes, but taking the age distribution into account it is likely that the vast majority of new cases were type 2 diabetes. Another strength is the use of a large random sample of the general population of Denmark, a country with a high prevalence of low vitamin D status. 30 Moreover, the use of serum 25(OH)D as an objective measure of vitamin D status is an important strength since 25(OH)D measures total vitamin D and not only dietary vitamin D. The single measurement did not, however, account for individual seasonal variation, but any misclassification is likely to be random and would reduce the association, resulting in an underestimation of the true association between 25(OH)D and diabetes risk. Finally, the availability of detailed information on important covariates reduced potential confounding. Nevertheless, residual confounding, e.g. by diet or obesity, or confounding by unmeasured confounders cannot be fully ruled out because of the observational design of this study, which is its major limitation.
In a previous study, we examined the association of serum 25(OH)D and incident diabetes defined on the basis of glycosylated haemoglobin (HbA1c) and an oral glucose tolerance test in another Danish general population sample. 31 Although the association was not statistically significant in the fully adjusted model, it was in the same order of magnitude as observed in the current study. In addition, in that study, we observed a significant association with unfavourable longitudinal changes in continuous markers of glucose homeostasis.
Several other studies examined the prospective association of blood 25(OH)D and diabetes incidence. [16] [17] [18] [19] [20] [21] [22] Three studies 16, 19, 20 One used pooled data from two Finnish cohorts: the Finnish Mobile Clinic Health Examination Survey and the Mini-Finland Health Survey, and found an inverse association in men, but not in women. 16 However, only patients receiving reimbursements for type 2 diabetes medications could be identified, resulting in misclassification of those treated with dietary changes only. In accordance with our results, a second study found a significant inverse association between 25(OH)D and the incidence of diabetes. 19 That study had a relatively short follow-up time (average 1.3 years), and was based on patients in whom 25(OH)D was measured for clinical indications e.g. risk of osteoporosis. On the contrary, a third study involving 11 years of follow-up found no association. 20 Another two studies were based on self-reported diabetes and were restricted to women. 17, 18 One was nested within the Nurses' Health study, and in agreement with our results, found that higher concentrations of plasma 25(OH)D were associated with a lower risk of self-reported incident type 2 diabetes. 17 In contrast, no association with 25(OH)D was observed in a post hoc analysis of three nested case-control studies within the Women's Health Initiative Clinical Trials and Observational study. 18 Finally, two studies defining diabetes based on glucose tolerance tests and HbA1c measurements have recently been published. 21, 22 The DPP study measured 25(OH)D repeatedly and found a significant association with incident diabetes in high-risk individuals, 22 whereas the other study based on only 351 older men and women was limited by low power and found no significant association. 21 At this time, no randomized intervention trial specifically designed to test the effect of vitamin D supplementation on incident diabetes in healthy individuals has been published. Results from post hoc analyses of randomized trials with other primary endpoints have been inconsistent. 14, 32, 33 The finding of an interaction between 25(OH)D and fat mass with respect to incident diabetes has not been reported previously. However, this finding is consistent with two cross-sectional studies reporting stronger associations between 25(OH)D and HbA1c and insulin sensitivity, respectively, in persons with higher versus lower BMI. 34, 35 On the one hand this suggests that overweight and obese individuals are more susceptible to the adverse effects of low vitamin D than normal weight persons. For example overweight and obese individuals may have an increased need for vitamin D in order to maintain normal glucose homeostasis. Experimental evidence suggests that the mechanism by which vitamin D may preserve glucose tolerance acts through effects on insulin secretion and sensitivity caused by effects on intracellular calcium, the regulation of insulin receptor expression in peripheral tissues, or the increased resilience of beta-cells to the systemic inflammation seen in type 2 diabetes. 32 On the other hand this could also suggest that vitamin D is not causally related to the development of diabetes but merely a marker of increased need as the disease develops.
In conclusion, our results suggest that low serum 25(OH)D may be associated with an increased risk of type 2 diabetes, especially in overweight and obese individuals. A randomized trial specifically designed to test the effect of vitamin D supplementation on incident diabetes in high-risk individuals is needed to confirm a causal relationship.
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